Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

6.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.3K
Genetic Screens02:46

Genetic Screens

5.8K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phylogenomic analysis of 20S proteasome gene family reveals stress-responsive patterns in rapeseed (<i>Brassica napus</i> L.).

Frontiers in plant science·2022
Same author

Zinner Syndrome.

Cureus·2022
Same author

Clinical and echocardiographic outcomes with new-onset left bundle branch block after SAPIEN-3 transcatheter aortic valve replacement.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2022
Same author

Design and Analysis of a Flexible Smart Apparel MIMO Antenna for Bio-Healthcare Applications.

Micromachines·2022
Same author

Economic impact of predominant ticks and tick-borne diseases on Indian dairy production systems.

Experimental parasitology·2022
Same author

An Update on Complications Associated with SARS-CoV-2 Infection and COVID-19 Vaccination.

Vaccines·2022

Related Experiment Video

Updated: Mar 13, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.2K

Preclinical screening methods in cancer.

Sachin Kumar1, Sakshi Bajaj2, Ramesh Babu Bodla3

  • 1Department of Pharmacology, DIPSAR, New Delhi, India.

Indian Journal of Pharmacology
|October 11, 2016
PubMed
Summary
This summary is machine-generated.

Choosing the right preclinical cancer models is crucial for drug development success. This review details various methods to improve anticancer drug screening and reduce clinical trial failures.

Keywords:
Cancer epidemiologycell line prescreengenetically engineered mousexenograft

More Related Videos

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model
07:03

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model

Published on: February 3, 2021

3.2K
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.8K

Related Experiment Videos

Last Updated: Mar 13, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.2K
Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model
07:03

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model

Published on: February 3, 2021

3.2K
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.8K

Area of Science:

  • Oncology
  • Pharmacology
  • Drug Discovery

Background:

  • Cancer is a leading global cause of death, characterized by uncontrolled cell growth.
  • A significant majority of anticancer drugs fail in clinical trials, often due to preclinical limitations.
  • Current preclinical screening methods have inherent advantages and disadvantages.

Purpose of the Study:

  • To provide an overview of preclinical methods used in anticancer drug screening.
  • To analyze the pros and cons of various *in vitro* and *in vivo* models.
  • To emphasize the importance of selecting appropriate models to improve drug development success rates.

Main Methods:

  • Review of established preclinical cancer models.
  • Comparative analysis of *in vitro* human cancer cell lines.
  • Evaluation of *in vivo* tumor xenograft and genetically engineered mouse models.

Main Results:

  • Each preclinical model possesses unique strengths and weaknesses.
  • Model selection significantly impacts the predictive value for clinical efficacy.
  • Diverse mechanisms of action require tailored preclinical approaches.

Conclusions:

  • Optimizing preclinical anticancer drug screening is essential to reduce high attrition rates.
  • Careful selection and application of preclinical models can enhance the success of anticancer compounds in clinical trials.
  • This review aids researchers in choosing appropriate methods for effective anticancer drug development.